Here you will find online publications released by the Military Health System. You can search for a specific publication by either scrolling down the page or entering a keyword in the search box.
Please note that files more than two years old may not be compliant with Section 508 of the Rehabilitation Act. If you need an accessible version of a particular file, please contact us and we will provide one for you.
If you're having trouble finding what you're looking for, consider using fewer words in your search criteria. Results are limited to content that matches all terms in the search field.
We found - potentially matching ""
Advanced Search Options
The NSI is used as a subjective measure for symptom reporting. The NSI is a 22-item symptom inventory of non-specific but common mild TBI symptoms.
The ISI is a brief, validated, seven-item self-report questionnaire useful for the initial assessment of insomnia symptom severity and ongoing monitoring of treatment response.
The GCS is used to assess the consciousness and neurological functioning of a person who has just received a TBI. The total score is the sum of the scores in three categories: eye-opening response, verbal response and motor response.
The ESS is widely used in the field of sleep medicine as a subjective measure of a patient's sleepiness. The test is a list of eight situations in which you rate your tendency to become sleepy on a scale of 0 - no chance of dozing, to 3 - high chance of dozing.
This clinical support tool gives providers an approach to evaluate visual dysfunction following mild TBI and offers guidance regarding referral for further eye or visual evaluation and care.
Recommended Content:
This clinical recommendation serves as a reference tool offering medical guidance following indications from post-injury neuroendocrine screening.
This clinical support tool serves as a quick reference offering medical guidance following indications from post-injury neuroendocrine screening.
The VOMS for Concussion Instructions is a clinical support tool for use with the MACE 2.
This clinical recommendation outlines the assessment and management of headache following mild TBI. It includes specific recommendations regarding how health care providers can help patients manage pharmacologic and non-pharmacologic treatment of post-traumatic headache (PTH).
DVBIC developed these training slides based on the latest coding guidance and the Military Health System Professional Services and Specialty Medical Coding Guidelines Version 5.0, to facilitate consistent and accurate coding for TBI diagnoses and related symptoms and conditions.
This document acknowledges those who participated in the expert working group and provides the resources used to update the Management of Sleep Disturbances following Concussion/Mild TBI: Guidance for Primary Care Management in Deployed and Non-Deployed Settings clinical recommendation.
This clinical recommendation outlines how to identify and assess sleep disturbances; primary care manager initial treatment options; and recommended conditions for referral to sleep medicine.
The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD. The PCL-5 has a variety of purposes, including: monitoring symptom change during and after treatment, screening individuals for PTSD and making a provisional PTSD diagnosis.
TBI treatment requirements are based on the severity of injury. This table shows how severity is assigned based on duration of symptoms. Alteration in consciousness (AOC) is often described as being dazed, confused or “having my bell rung.” Post-traumatic amnesia (PTA) is not loss of memory but the inability to lay down new memories. This is often determined by finding out the first thing a patient remembers. It is important to note that a loss of consciousness (LOC) is required for a mild TBI diagnosis. When parameters fall in more than one category, the more severe category is usually assigned.
The PHQ-9 is a nine-item tool commonly used in the primary care setting to assess the presence and severity of depression symptoms.
DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101
The appearance of hyperlinks does not constitute endorsement by the Defense Health Agency of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.